These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1494490)

  • 1. Calcium-dependent pro-cholecystokinin V-9-M immunoreactive peptide release from rat brain slices and CCK-secreting rat medullary thyroid carcinoma cells in culture.
    Cao G; Beinfeld MC
    Peptides; 1992; 13(6):1087-90. PubMed ID: 1494490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of pro-cholecystokinin (CCK) sulfation by treatment with sodium chlorate alters its processing and decreases cellular content and secretion of CCK 8.
    Beinfeld MC
    Neuropeptides; 1994 Mar; 26(3):195-200. PubMed ID: 8208365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The subcellular distribution of peptides immunoreactive for the amino-terminal of pro-cholecystokinin in rat brain.
    Allard LR; Beinfeld MC
    Regul Pept; 1985 Sep; 12(1):59-66. PubMed ID: 4070687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a cholecystokinin-producing rat medullary thyroid carcinoma cell line.
    Haun RS; Beinfeld MC; Roos BA; Dixon JE
    Endocrinology; 1989 Aug; 125(2):850-6. PubMed ID: 2752980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of cholecystokinin release from rat caudatoputamen in vitro.
    Gysling K; Beinfeld MC
    Brain Res; 1987 Mar; 407(1):110-6. PubMed ID: 2884011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and processing of procholecystokinin in a rat medullary thyroid carcinoma cell line.
    Odum L; Rehfeld JF
    Biochem J; 1990 Oct; 271(1):31-6. PubMed ID: 2222420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prohormone convertase 1 (PC1) when expressed with pro cholecystokinin (pro CCK) in L cells performs three endoproteolytic cleavages which are observed in rat brain and in CCK-expressing endocrine cells in culture, including the production of glycine and arginine extended CCK8.
    Wang W; Birch NP; Beinfeld MC
    Biochem Biophys Res Commun; 1998 Jul; 248(3):538-41. PubMed ID: 9703961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cholecystokinin secretion from a rat medullary thyroid carcinoma cell line: role of calcium, cyclic nucleotides, glucocorticoids, neurotensin, and calcitonin gene-related peptide.
    Beinfeld MC; Haun RS; Allard LR; Dixon JE
    Peptides; 1992; 13(3):545-50. PubMed ID: 1523166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cholecystokinin forms by medullary thyroid cancer.
    Poston GJ; Draviam EJ; Seitz PK; Rajaraman S; Alexander RW; Cooper CW; Townsend CM; Thompson JC
    Int J Cancer; 1991 Jul; 48(5):689-92. PubMed ID: 2071230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro release of cholecystokinin octapeptide-like immunoreactivity from rat brain synaptosomes.
    Klaff LJ; Hudson A; Sheppard M; Tyler M
    S Afr Med J; 1981 Jan; 59(5):158-60. PubMed ID: 7455849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides in rat brain immunoreactive for the amino terminus of cholecystokinin 33: distribution and chromatography.
    Han SP; Allard LR; Beinfeld MC
    Biochem Biophys Res Commun; 1987 Dec; 149(3):902-7. PubMed ID: 3426615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices.
    Migaud M; Roques BP; Durieux C
    Neuropharmacology; 1994 Jun; 33(6):737-43. PubMed ID: 7936111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.
    Herzig KH; Schön I; Tatemoto K; Ohe Y; Li Y; Fölsch UR; Owyang C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7927-32. PubMed ID: 8755579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems.
    Yaksh TL; Furui T; Kanawati IS; Go VL
    Brain Res; 1987 Mar; 406(1-2):207-14. PubMed ID: 3032357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices.
    Ferraro L; Beani L; Trist D; Reggiani A; Bianchi C
    J Neurochem; 1999 Nov; 73(5):1973-81. PubMed ID: 10537055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists.
    Hutchison JB; Strupish J; Nahorski SR
    Brain Res; 1986 Apr; 370(2):310-4. PubMed ID: 3708329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing, release and metabolism of cholecystokinin in SK-N-MCIXC cells.
    Konings PN; Mania-Farnell B; Beinfeld MC; Oakes MG; Day R; Seidah NG; Davis TP
    Neuropeptides; 1993 Jul; 25(1):19-30. PubMed ID: 8413849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord.
    Yaksh TL; Abay EO; Go VL
    Brain Res; 1982 Jun; 242(2):279-90. PubMed ID: 6896838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomas.
    Reubi JC; Waser B
    Int J Cancer; 1996 Sep; 67(5):644-7. PubMed ID: 8782652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D3 effects on basal and cAMP modulated expression of cholecystokinin and somatostatin genes in a rat medullary thyroid carcinoma cell line [CA-77].
    Odum L; Bundgaard JR; Monstein HJ
    Neuropeptides; 1995 Jul; 29(1):45-51. PubMed ID: 7566512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.